What You Should Know About CDH1 Pathogenic/Likely Pathogenic Variants
Individuals with a pathogenic/likely pathogenic (P/LP) variant in the CDH1 gene have an increased risk for cancers of the stomach and breast.
UT Southwestern Medical Center is home to one of the largest hereditary cancer programs in the nation, offering expert care and experience in treating individuals with CDH1 P/LP variants.
Cancer Risks Associated with a CDH1 Mutation
Individuals with a CDH1 P/LP variant have an increased risk for a specific type of stomach cancer called diffuse or signet ring carcinoma. The lifetime risk for females with the variant to get this cancer is up to 35%, and for males with the variant it is up to 45%. Females with the variant also have up to a 55% lifetime risk for breast cancer. The type of breast cancer tends to be lobular breast cancer.